Company Filing History:
Years Active: 2005-2010
Title: Innovations of Jeremy G Richman in Metabolic-Related Disorders
Introduction
Jeremy G Richman is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of metabolic-related disorders through his innovative research and patents. With a total of two patents to his name, Richman is recognized for his work on human G protein-coupled receptors.
Latest Patents
Richman's latest patents focus on methods of identifying candidate compounds that act as modulators of G protein-coupled receptors (GPCRs). These inventions are particularly relevant for therapeutic applications in treating metabolic-related disorders. The first patent discusses GPCRs that are coupled to Gi, which lowers intracellular cAMP levels and is expressed by adipocytes. The second patent elaborates on the same GPCRs and their potential as therapeutic agents for conditions such as dyslipidemia, atherosclerosis, coronary heart disease, stroke, insulin resistance, and type 2 diabetes.
Career Highlights
Richman is currently associated with Arena Pharmaceuticals, Inc., where he continues to advance his research in the field. His work has been instrumental in developing new therapeutic strategies for metabolic disorders, showcasing his commitment to improving health outcomes.
Collaborations
Some of his notable coworkers include David J Unett and Ruoping Chen, who have collaborated with him on various projects related to GPCRs and metabolic disorders.
Conclusion
Jeremy G Richman's innovative work in the field of metabolic-related disorders highlights the importance of research in developing effective treatments. His contributions through patents and collaborations continue to pave the way for advancements in medical science.